COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation
Over the Counter Rapid Antigen Test for Detection of SARS-CoV-2 Virus: Clinical Evaluation
Sponsor: MP Biomedicals, LLC
This NA trial investigates COVID-19 and SARS-CoV2 Infection and is currently completed. MP Biomedicals, LLC leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2023 — Jul 2024 [monthly]
Completed NA
-
Jul 2023 — Dec 2023 [monthly]
Completed NA
▶ Show 1 earlier version
-
Nov 2022 — Jul 2023 [monthly]
Completed NA
First recorded
Dec 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- MP Biomedicals, LLC
- New Day Diagnostics
For direct contact, visit the study record on ClinicalTrials.gov .